The Karma system is currently undergoing maintenance (Monday, January 29, 2018).
The maintenance period has been extended to 8PM EST.
Karma Credits will not be available for redeeming during maintenance.
Emerging Technologies, Medical Devices, Apps, Sensors, and Informatics to Help People with Diabetes.
JMIR Diabetes (JD) is a new sister journal of JMIR (the leading open-access journal in health informatics (Impact Factor 2017: 4.671), focusing on technologies, medical devices, apps, engineering, informatics and patient education for diabetes prevention, self-management, care, and cure, to help people with diabetes. As open access journal we are read by clinicians and patients alike and have (as all JMIR journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies, as well as on diabetes epidemiology. We publish original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews) covering for example wearable devices and trackers, mobile apps, glucose monitoring (including emerging technologies such as Google contact lens), medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and "quantified self", diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes.
Right click to copy or hit: ctrl+c (cmd+c on mac)
Background: Diabetes is increasing in prevalence and complexity in the care home setting, affecting up to a quarter of care home residents. Health outcomes for these residents are impacted by manageme...
Background: Diabetes is increasing in prevalence and complexity in the care home setting, affecting up to a quarter of care home residents. Health outcomes for these residents are impacted by management of the disease, healthcare professionals’ decision-making skills within the care home setting, and access to specialist services. The use of technology has the potential to recognise opportunities for early intervention enabling efficient responsive care, and taking a fundamental role in linking the care home community to wider multi-disciplinary teams for support. Objective: To identify evidence that explores factors relevant to the use of technology in and around the care home setting for the management of diabetes. Methods: Databases searched using a structured pre-specified approach included: PUBMED, CINAHL, OVID Nursing database, SCOPUS, MEDLINE, Cochrane Library and the KINGS FUND from 2012- 2017, handsearching was undertaken additionally for any grey literature. PRISMA P was used as protocol with ROBIS to assess the risk of bias across studies. Studies had to include interventions that combined technology to or from the care home setting to support residents living with diabetes. Results: The combined search strategy identified a total of 493 electronic records.171 were screened for eligibility, 66 full papers were accessed and 13 have been included in this study. Interpretive synthesis has identified different strands of research evidence in what and how technology is currently being used in and around care homes to enhance diabetes management. New initiatives and implementations of technology and emerging models of care that included the use of technology have also been included. Conclusions: By triangulating the perspectives of healthcare professionals, practitioners, specialists and members of the care home community, the authors anticipate that this review will represent an up to date, evidenced-based overview of the potential for using technology within the care home setting for diabetes management as well as stimulate research in this area. Clinical Trial: N/A